Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» OncoGenex Regains Rights to Custirsen from Teva
OncoGenex Regains Rights to Custirsen from Teva
OncoGenex Regains Rights to Custirsen from Teva
Submitted by
admin
on April 27, 2015 - 9:43am
Source:
Yahoo
News Tags:
OncoGenex
custirsen
Teva Pharmaceutical
lung cancer
prostate cancer
Headline:
OncoGenex Regains Rights to Custirsen from Teva
Do Not Allow Advertisers to Use My Personal information
